# Mometasone furoate (skin cream)

Source: https://onco.cc/drugs/mometasone/  
OnCo record `mometasone` (Treatment). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Mometasone is a steroid cream. MASCC experts recommend it to help prevent the skin reaction that radiotherapy can cause.

## Summary

The US label for mometasone furoate 0.1% cream covers "the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses" from 2 years of age. The MASCC Delphi consensus on acute radiation dermatitis (Lancet Oncol 2023) recommended six interventions for prevention: "photobiomodulation therapy and Mepitel film in people with breast cancer, Hydrofilm, mometasone, betamethasone, and olive oil". The Elocon NDA was approved on 30 April 1987.

## Fields

- Kind: Treatment
- Status: approved
- Last checked: 2026-11-11
- Also known as: mometasone
- Tags: supportive; generic; supportive-care-gaps-2026-11
- Brand: Elocon
- Modality: Medium-potency topical corticosteroid
- Mechanism: A topical corticosteroid that reduces skin inflammation and itch.
- Approvals: US 1987: Inflammatory and itchy manifestations of corticosteroid-responsive dermatoses

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Mometasone_furoate
- US label (DailyMed): mometasone furoate cream 0.1%: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16e134c7-39fb-4d16-9c24-a6df438967bf
- Behroozian et al., MASCC clinical practice guidelines for the prevention and management of acute radiation dermatitis (Lancet Oncol 2023): https://doi.org/10.1016/S1470-2045(23)00067-0

## Connected records

- terms: [Radiation dermatitis (skin reaction)](https://onco.cc/terms/radiation-dermatitis/)

---
JSON: https://onco.cc/api/v1/entities/mometasone.json